Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter

Abstract

BackgroundThe first wave of pandemic influenza A(H1N1)2009 (pH1N1) reached New South Wales (NSW), Australia in May 2009, and led to high rates of influenza-related hospital admission of infants and young to middle-aged adults, but no increase in influenza-related or all-cause mortality.Methodology/Principal FindingsTo assess the population rate of pH1N1 infection in NSW residents, pH1N1-specific haemagglutination inhibition (HI) antibody prevalence was measured in specimens collected opportunistically before (2007–2008; 474 specimens) and after (August–September 2009; 1247 specimens) the 2009 winter, and before the introduction of the pH1N1 monovalent vaccine. Age- and geographically-weighted population changes in seroprevalence were calculated. HI antibodies against four recent seasonal influenza A viruses were measured to assess cross-reactions. Pre- and post-pandemic pH1N1 seroprevalences were 12.8%, and 28.4%, respectively, with an estimated overall infection rate of 15.6%. pH1N1 antibody prevalence increased significantly - 20.6% overall - in people born since 1944 (26.9% in those born between 1975 and 1997) but not in those born in or before 1944. People born before 1925 had a significantly higher pH1N1 seroprevalence than any other age-group, and against any seasonal influenza A virus. Sydney residents had a significantly greater change in prevalence of antibodies against pH1N1 than other NSW residents (19.3% vs 9.6%).Conclusions/SignificanceBased on increases in the pH1N1 antibody prevalence before and after the first pandemic wave, 16% of NSW residents were infected by pH1N1 in 2009; the highest infection rates (27%) were among adolescents and young adults. Past exposure to the antigenically similar influenza A/H1N1(1918) is the likely basis for a very high prevalence (49%) of prepandemic cross-reacting pH1N1 antibody and sparing from pH1N1 infection among people over 85 years. Unless pre-season vaccine uptake is high, there are likely to be at least moderate rates including some life-threatening cases of pH1N1 infection among young people during subsequent winters.

The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel

“…Most of the results discussed earlier correlate well with previous publications describing the dynamics of the pandemic virus infections in different countries and age distribution 1, 11, 18, 19, 20, 21, 22…”

Seroprevalence to Influenza A(H1N1) 2009 Virus—Where Are We?

“…In the United Kingdom, about 20% of the over-65-year-olds had cross-reactive antibodies against the 2009 virus before the pandemic while in the other age groups lower rates of seroprevalence were observed (16,27). Similar patterns were found in Italy (30), Taiwan (18), New Zealand (5), and Australia (26), with over 60% of samples being positive in some cohorts older than 85 years (13). In contrast, in Singapore and Hong Kong, the baseline seroprevalence in all age groups was equal to or below 5% (9,38), and in China no preexisting antibodies could be shown in rural farmers aged over 60 years (8).…”

“…Several studies from different continents have shown high levels of cross-reactive antibodies to A(H1N1) 2009 in the serum of donors who had been exposed to the 1918 influenza virus (13,19,20), suggesting long-lasting immunologic memory of the initial influenza (11,19,39). These results could explain the reduced attack rates among older individuals during the 2009 pandemic.…”

Strengthening public health systems: assessing the attributes of the NSW influenza surveillance system

“…Sensitivity at the peak of the season corresponds to data from a seroprevalence survey conducted in NSW following the 2009 pandemic, which calculated the population rate of pandemic H1N1 influenza infection to be 28%. 24 However, it is known that a range of factors contribute to this result, including health-seeking behaviour, clinical testing practices and the prevalence of influenza.…”